22. Diagnosis and Treatment of Neonatal Hypothyroidism

Author(s):  
Stephen H. LaFranchi
2011 ◽  
Vol 96 (10) ◽  
pp. 2959-2967 ◽  
Author(s):  
Stephen H. LaFranchi

Abstract Congenital hypothyroidism, occurring in 1:3000 newborns, is one of the most common preventable causes of mental retardation. Neurodevelopmental outcome is inversely related to the age of diagnosis and treatment. Infants detected through newborn screening programs and started on l-T4 in the first few weeks of life have a normal or near-normal neurodevelopmental outcome. The recommended starting dose of l-T4 (10–15 μg/kg · d) is higher on a weight basis than the dose for children and adults. Tailoring the starting l-T4 dose to the severity of the hypothyroidism will normalize serum T4 and TSH as rapidly as possible. It is important to obtain confirmatory serum thyroid function tests before treatment is started. Further diagnostic studies, such as radionuclide uptake and scan and ultrasonography, may be performed to determine the underlying cause of hypothyroidism. Because results from these tests generally do not alter the initial treatment decision, however, these diagnostic studies are rarely indicated. The developing brain has a critical dependence on thyroid hormone for the first 2–3 yr of life; thus, monitoring occurs at more frequent intervals than in older children and adults. Serum free T4 and TSH should be checked at intervals frequent enough to ensure timely adjustment of l-T4 dosing and to keep serum free T4 and TSH levels in target ranges. Given the success of early detection and treatment of neonates with congenital hypothyroidism, a public health mandate should be to develop similar programs for the 75% of babies worldwide who are born in areas without newborn screening programs.


PEDIATRICS ◽  
1982 ◽  
Vol 70 (1) ◽  
pp. 16-20
Author(s):  
◽  

This report reviews problems encountered during the first five years of operation of the New England Regional Screening Program. Human error was responsible for either overlooked or delayed diagnosis and treatment in 14/159 infants with hypothyroidism. This group consisted of three infants who were never tested, six infants whose diagnosis was missed because of errors during the processing of the blood specimens, and five additional children in whom the diagnosis of hypothyroidism could not be made at birth because the concentrations of thyroid-stimulating hormone were not elevated. Many of the problems, most of which occurred during the first two years of the study, have been eliminated by improved communication and monitoring. This study emphasizes the potential vulnerability of all screening programs and underscores the need for physicians to continue to exercise their best clinical judgement regardless of the circumstances.


JAMA ◽  
1966 ◽  
Vol 195 (3) ◽  
pp. 193-194
Author(s):  
E. N. Cook

JAMA ◽  
1966 ◽  
Vol 197 (2) ◽  
pp. 133-134 ◽  
Author(s):  
H. Najafi

ASHA Leader ◽  
2013 ◽  
Vol 18 (1) ◽  
pp. 36-47
Author(s):  
Jennifer Stone ◽  
Edwin Rubel ◽  
Robert E. Hillman ◽  
Matthew Cutter ◽  
Shannon C. Mauszycki ◽  
...  

These 11 up-and-coming technologies could revolutionize diagnosis and treatment of speech, language and hearing disorders.


2004 ◽  
Vol 171 (4S) ◽  
pp. 466-466
Author(s):  
Stephen A. Boorjian ◽  
Casey K. Ng ◽  
Ravi Munver ◽  
R. Ernest Sosa ◽  
E. Darracott Vaughan ◽  
...  

1952 ◽  
Vol 36 (5) ◽  
pp. 1341-1355 ◽  
Author(s):  
Thomas A. Wartiiin ◽  
Willard Dalrymple

Sign in / Sign up

Export Citation Format

Share Document